Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands

Cancer Causes and Control

Volumn 15, Issue 8, 2004, Pages 787-796

  Vrieling, Alina ^a   Voskuil, Dorien W ^a   Mesquita, H Bas Bueno De ^b   Kaaks, Rudolf ^c   Noord, Paul A H Van ^d   Keinan Boker, Lital ^d   Gils, Carla H Van ^d   Peeters, Petra H M ^d  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

diet; IGF binding proteins (IGFBPs); insulin like growth factor I (IGF I); lycopene; phytoestrogens

Indexed keywords

ALCOHOL; LIGNAN DERIVATIVE; LYCOPENE; PHYTOESTROGEN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CALORIC INTAKE; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DIET; PROTEIN INTAKE; QUESTIONNAIRE; RISK ASSESSMENT;

AGED; CROSS-SECTIONAL STUDIES; DIET; ENERGY INTAKE; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; NEOPLASMS; NETHERLANDS; PHYTOESTROGENS; POSTMENOPAUSE; PREGNANCY PROTEINS; PREMENOPAUSE; RISK FACTORS; VEGETABLES;

EID: 5044221278     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000043429.51915.c6     Document Type: Article

References (60)

1. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21: 215-244.
2. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
3. Stattin P, Bylund A, Rinaldi S, et al. (2000) Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst 92: 1910-1917.
4. Hankinson SE, Willett WC, Colditz GA, et al. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396.
5. Toniolo P, Bruning PF, Akhmedkhanov A, et al. (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832.
6. Ma J, Pollak MN, Giovannucci E, et al. (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625.
7. Giovannucci E, Pollak MN, Platz EA, et al. (2000) A prospective study of plasma insulin-like growth factor-I and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349.
8. Kaaks R, Toniolo P, Akhmedkhanov A, et al. (2000) Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92: 1592-1600.
9. Collett-Solberg PF, Cohen P (2000) Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 12: 121-136.
10. Harrela M, Koistinen H, Kaprio J, et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98: 2612-2615.
11. Thissen JP, Ketelslegers JM, Underwood LE (1994) Nutritional regulation of insulin-like growth factors. Endocr Rev 15: 80-101.
12. Darling-Raedeke M, Thornton WH, MacDonald RS (1998) Growth hormone and IGF-I plasma concentrations and macronutrient intake measured in a free-living elderly population during a one-year period. J Am Coll Nutr 17: 392-397.
13. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS (1999) Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J Clin Oncol 17: 3291-3298.
14. Mucci LA, Tamimi R, Lagiou P, et al. (2001) Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 87: 814-820.
15. Signorello LB, Kuper H, Lagiou P, et al. (2000) Lifestyle factors and insulin-like growth factor 1 levels among elderly men. Eur J Cancer Prev 9: 173-178.
16. Chang S, Wu X, Yu H, Spitz MR (2002) Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev 11: 758-766.
17. Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ (2002) The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev 11: 1441-1448.
18. Gunnell D, Oliver SE, Peters TJ, et al. (2003) Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer 88: 1682-1686.
19. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K (2003) Dietary soy and fats in relation to serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 levels in premenopausal Japanese women. Nutr Cancer 45: 185-189.
20. Probst-Hensch NM, Wang H, Goh VH, Seow A, Lee HP, Yu MC (2003) Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women. Cancer Epidemiol Biomarkers Prev 12: 739-746.
21. Devine A, Rosen C, Mohan S, Baylink D, Prince RL (1998) Effects of zinc and other nutritional factors on insulin-like growth factor I and insulin-like growth factor binding proteins in postmenopausal women. Am J Clin Nutr 68: 200-206.
22. Holmes MD, Pollak MN, Willett WC, Hankinson SE (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11: 852-861.
23. Giovannucci E, Pollak M, Liu Y, et al. (2003) Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 12: 84-89.
24. Heald AH, Cade JE, Cruickshank JK, Anderson S, White A, Gibson JM (2003) The influence of dietary intake on the insulin-like growth factor (IGF) system across three ethnic groups: a population-based study. Public Health Nutr 6: 175-180.
25. Yu H (1998) Alcohol consumption and breast cancer risk. JAMA 280: 1138-1139.
26. Goodman-Gruen D, Barrett-Connor E (1997) Epidemiology of insulin-like growth factor-I in elderly men and women: the Rancho Bernardo Study. Am J Epidemiol 145: 970-976.
27. Ho GH, Ji CY, Phang BH, Lee KO, Soo KC, Ng EH (1998) Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study. Ann Surg Oncol 5: 361-367.
28. Bonanni B, Johansson H, Gandini S, et al. (2001) Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. Breast Cancer Res Treat 69: 21-27.
29. Torrisi R, Baglietto L, Johansson H, et al. (2001) Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer. Br J Cancer 85: 1838-1841.
30. Setchell KD (2001) Soy isoflavones - benefits and risks from nature's selective estrogen receptor modulators (SERMs). J Am Coll Nutr 20: 354S-362S.
31. Wangen KE, Duncan AM, Merz-Demlow BE, et al. (2000) Effects of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J Clin Endocrinol Metab 85: 3043-3048.
32. Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH (2002) Soy protein supplementation increases serum insulin-like growth factor- I in young and old men but does not affect markers of bone metabolism. J Nutr 132: 2605-2608.
33. Adams KF, Newton KM, Chen C, et al. (2003) Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial. J Nutr 133: 1316-1319.
34. Levy J, Bosin E, Feldman B, et al. (1995) Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene. Nutr Cancer 24: 257-266.
35. Karas M, Amir H, Fishman D, et al. (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36: 101-111.
36. Liu C, Lian F, Smith DE, Russell RM, Wang XD (2003) Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets. Cancer Res 63: 3138-3144.
37. Riboli E (1992) Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 10: 783-791.
38. Keinan-Boker L, van Noord PAH, van der Schouw YT, et al. (2001) Prospect-EPIC Utrecht: study design and characteristics of the cohort population. European Prospective Investigation into Cancer and Nutrition. Eur J Epidemiol 17: 1047-1053.
39. Voskuil DW, Bueno de Mesquita HB, Kaaks R, et al. (2001) Determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1-3 in pre-menopausal women: physical activity and anthropometry (Netherlands). Cancer Causes Control 12: 951-958.
40. Keinan-Boker L, Bueno de Mesquita HB, Kaaks R, et al. (2003) Circulating levels of insulin-like growth factor I, its binding proteins -1, -2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106: 90-95.
41. Voorrips LE, Ravelli ACJ, Dongelmans PCA, Deurenberg P, van Staveren WA (1991) A physical activity questionnaire for the elderly. Med Sci Sports Exer 23: 974-979.
42. Ocké MC, Bueno de Mesquita HB, Goddijn HE, et al. (1997) The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26(Suppl 1): S37-S48.
43. Ocké MC, Bueno de Mesquita HB, Pols MA, Smit HA, van Staveren WA, Kromhout D (1997) The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26(Suppl 1): S49-S58.
44. de Kleijn MJ, van der Schouw YT, Wilson PW, et al. (2001) Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J Nutr 131: 1826-1832.
45. Keinan-Boker L, van der Schouw YT, de Kleijn MJJ, Jacques PF, Grobbee DE, Peeters PHM (2002) Intake of dietary phytoestrogens by Dutch women. J Nutr 132: 1319-1328.
46. Willett W, Stampfer MJ (1986) Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 124: 17-27.
47. World Cancer Research Fund (1997) Food, Nutrition and the Prevention of Cancer: a Global Perspective. Washington, DC: American Institute for Cancer Research.
48. Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and IGF-I. Proc Nutr Soc 60: 91-106.
49. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85: 1700-1705.
50. Hamajima N, Hirose K, Tajima K, et al. (2002) Alcohol, tobacco and breast cancer - collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer 87: 1234-1245.
51. Smith-Warner SA, Spiegelman D, Yaun SS, et al. (1998) Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279: 535-540.
52. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK (1999) Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129: 1628-1635.
53. Lamartiniere CA, Cotroneo MS, Fritz WA, Wang J, Mentor-Marcel R, Elgavish A (2002) Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132: 552S-558S.
54. Chen J, Stavro PM, Thompson LU (2002) Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor. Nutr Cancer 43: 187-192.
55. Arjmandi BH, Khalil DA, Smith BJ, et al. (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88: 1048-1054.
56. Giovannucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature [see comments]. J Natl Cancer Inst 91: 317-331.
57. Kucuk O, Sarkar FH, Sakr W, et al. (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10: 861-868.
58. Horn-Ross PL, Lee M, John EM, Koo J (2000) Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 11: 299-302.
59. Goldbohm RA, Brants HA, Hulshof KF, van den Brandt PA (1998) The contribution of various foods to intake of vitamin A and carotenoids in The Netherlands. Int J Vitam Nutr Res 68: 378-383.
60. O'Neill ME, Carroll Y, Corridan B, et al. (2001) A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr 85: 499-507.